Filing Details
- Accession Number:
- 0001214659-20-007366
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-19 08:55:53
- Reporting Period:
- 2020-08-18
- Accepted Time:
- 2020-08-19 08:55:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1398733 | Aquestive Therapeutics Inc. | AQST | Pharmaceutical Preparations (2834) | 208623253 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739025 | T. John Maxwell | C/O Aquestive Therapeutics, Inc. 30 Technology Drive Warren NJ 07059 | Svp-Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-08-18 | 3,000 | $8.00 | 150,614 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 16, 2020.
Billionaire Hedge Funds
